|
Synonyms: AOC 1020 | AOC-1020 | del-brax
Compound class:
Nucleic acid
Comment: Delpacibart braxlosiran is structurally a monoclonal antibody (mAb)-oligonucleotide conjugate (AOC) in which the mAb binds the transferrin receptor (TFRC;) for targeted delivery of a small interfering RNA (siRNA) payload that targets double homeobox 4 (DUX4) mRNA [1].
This entry provides information on the siRNA as the component that mediates the agent's intended pharmacodynamic effect. Further details about the parental anti-TFRC mAb are provided in the delpacibart entry. To improve pharmacokinetics and RNA binding the nucleotides in braxlosiran (siDUX4.6) are chemically modified (2'-O-methyl/2'-MOE and 2'-deoxy-2'-fluoro/2'-F monomers), with a mixed phosphorothioate/phosphate backbone. The delpacibart component is attached at the 5' end of the passenger strand via a malemide linker Aberrant activation of the DUX4 gene in skeletal muscle causes the progressive muscle-wasting disease facioscapulohumeral muscular dystrophy (FSHD). The braxlosiran siRNA is intended to reduce DUX4 expression in skeletal muscle [1]. |
| References |
|
1. Malecova B, Sala D, Melikian GM, Johns R, Erdogan G, Hartmann M, Jordan M, Arias JD, Bhattacharya A, Meng Q et al.. (2026)
Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD. Nucleic Acids Res, 54 (7). [PMID:41994867] |